Centiva Capital’s Ocugen OCGN Stock Holding History

Centiva Capital’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-237,500	Closed	-$202K	–	1885
2023 Q1	$202K	Buy	+237,500	New	+$259K	0.01%	1238
2021 Q4	–	Sell	-10,608	Closed	-$76K	–	1443
2021 Q3	$76K	Buy	+10,608	New	+$77.9K	﹤0.01%	1093

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Luminus Management Houston, Texas $146M AUM 27.83% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Centiva Capital's OCGN Position: Q2 2023 in Review

Centiva Capital sold out of Ocugen (OCGN) in Q2 2023, closing a stake of 237,500 shares — an estimated $202K sold.

Centiva Capital first reported a position in OCGN in Q3 2021 and held it in 2 quarters. The position peaked at $202K in Q1 2023. 96 funds tracked by Wall St. Rank hold OCGN as of Q2 2023.

Centiva Capital reported no remaining Ocugen position as of Q2 2023 after selling out during the quarter.
Centiva Capital sold 237,500 Ocugen shares in Q2 2023, an estimated $202K.
Centiva Capital first reported a position in Ocugen in Q3 2021 and held it in 2 quarters.
Centiva Capital's Ocugen position peaked at $202K in Q1 2023.
96 funds tracked by Wall St. Rank held Ocugen as of Q2 2023.

Based on Centiva Capital's 13F filing for Q2 2023, filed 14 Aug 2023.